Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;6(6):1292-300.
doi: 10.2215/CJN.08350910. Epub 2011 May 5.

Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis

Stephen M Sozio  1 , Josef Coresh, Bernard G Jaar, Nancy E Fink, Laura C Plantinga, Paige A Armstrong, J Craig Longenecker, A Richey Sharrett, Neil R Powe, Rulan S Parekh
Affiliations

Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis

Stephen M Sozio et al. Clin J Am Soc Nephrol. 2011 Jun.

Abstract

Background and objectives: Stroke remains a leading cause of morbidity and mortality for patients on dialysis; however, its risk factors in this population and measures to prevent it are not well understood.

Design, setting, participants, & measurements: We investigated whether inflammation was associated with cerebrovascular events in a national US cohort of 1041 incident dialysis patients enrolled from October 1995 to June 1998 and followed until January 31, 2004. Incident cerebrovascular events were defined as nonfatal (hospitalized stroke, carotid endarterectomy) and fatal (stroke death) events after dialysis initiation. With Cox proportional hazards regression analysis accounting for the competing risk of nonstroke death, we assessed the independent event risk associated with baseline levels of multiple inflammatory markers (high-sensitivity C-reactive protein [hsCRP], interleukin-6 (IL-6), matrix metalloproteinase-3 [MMP-3], and P-selectin) and hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor (statin) use, which may have pleiotropic inflammatory effects.

Results: 165 patients experienced a cerebrovascular event during 3548 person-years of follow-up; overall incidence rate was 4.9/100 person-years. None of the inflammatory markers were associated with cerebrovascular event risk (adjusted hazard ratios [HRs] per log unit [95% confidence interval]: hsCRP, 0.97 [0.85 to 1.11]; IL-6, 1.04 [0.85 to 1.26]; MMP-3, 1.02 [0.70 to 1.48]; P-selectin, 0.98 [0.57 to 1.68]). Statin use was also not associated with significant risk of events in unadjusted (HR 1.07 [0.69 to 1.68]) or propensity-score adjusted analyses (HR 0.98 [0.61 to 1.56]).

Conclusions: In conclusion, neither inflammatory markers nor statin use was associated with risk of cerebrovascular events. Further studies are needed to understand the pathophysiology and prevention of stroke in patients on dialysis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Distribution of baseline inflammatory markers in incident dialysis patients. Markers measured a median of 1.22 to 1.35 months after study enrollment. For hsCRP, n = 866. For IL-6, n = 865. For MMP-3, n = 818. For P-selectin, n = 819. *Above the linear range of the assay. IQR, interquartile range.
Figure 2.
Figure 2.
Time to first cerebrovascular event in incident dialysis patients, by statin use. *Adjusted hazard ratio (aHR) of cerebrovascular events by statin use from competing risk model accounting for death from causes other than stroke, adjusted for age, gender, race, baseline dialysis modality, and propensity to use statins score.
See this image and copyright information in PMC

References

    1. Seliger SL, Gillen DL, Longstreth WT, Jr, Kestenbaum B, Stehman-Breen CO: Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 64: 603–609, 2003 - PubMed
    1. Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W: Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: The ARIC Study. Kidney Int 64: 610–615, 2003 - PubMed
    1. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208–2218, 2004 - PubMed
    1. Ishida I, Hirakata H, Sugimori H, Omae T, Hirakata E, Ibayashi S, Kubo M, Fujishima M: Hemodialysis causes severe orthostatic reduction in cerebral blood flow velocity in diabetic patients. Am J Kidney Dis 34: 1096–1104, 1999 - PubMed
    1. Tripepi G, Mattace-Raso F, Rapisarda F, Stancanelli B, Malatino L, Witteman J, Zoccali C, Mallamaci F: Traditional and nontraditional risk factors as predictors of cerebrovascular events in patients with end stage renal disease. J Hypertens 28: 2468–2474, 2010 - PubMed

Publication types

MeSH terms

Substances